Indicon Società Benefit (SB)’s Post

✨ Siamo lieti di condividere la pubblicazione nel nostro studio "Using the Nephrology Referral Form in Italian primary care to improve the care pathway of patients with anaemia or other complications related to Chronic Kidney Disease: survey findings" sulla rivista #AboutOpen.   L’indagine ha esaminato l'uso nella pratica clinica dei medici di medicina generale della #SchedaNefrologica (SN) – coprogettata da #ISHEO assieme a un team multidisciplinare di nefrologi, medici specialisti di medicina interna e medici di medicina generale. La scheda permette di identificare precocemente e in maniera appropriata la Malattia Renale Cronica (MRC) e migliorare il percorso di cura dei pazienti.    Principali Risultati dell'Indagine:   🔹 Utilizzo della SN: Dopo sei mesi di utilizzo, il 41,67% dei medici di base la utilizzava almeno una volta a settimana   🔹 Consensus sull'Utilità della SN: Il 96% dei medici di base ha riconosciuto l'utilità della SN nell'identificare i casi di MRC, sottolineando il suo valore nella diagnosi precoce.   🔹 Aumento delle Visite Specialistiche: L'83% dei medici di base ha segnalato un aumento del referral dei pazienti allo specialista rispetto ai sei mesi precedenti, indicando un miglioramento nel processo di refertazione e una maggiore collaborazione con gli specialisti.    Per saperne di più e per scoprire come questi risultati potrebbero influenzare positivamente la gestione della MRC nelle cure primarie clicca qui: 👉  https://lnkd.in/dHFJkGTh #ISHEO #ACCESSMATTERS #MRC #ANEMIA #MALATTIARENALECRONICA

Check out IBEX Innovations latest publication showing the performance of IBEX BH as a method for screening patients for osteoporosis. Read the full article here: https://lnkd.in/ezgNfRzw #Digitalhealth #healthcare #healthtech #innovation #event #GIANT2024

In occasione della XV edizione del congresso Top Ten in gastroenterologia, fabio pace, gastroenterologo e presidente dell’evento, ha illustrato le principali novità e riflessioni sul ruolo del microbioma umano nella salute. #microbiota | #health | #digitalhealth | #salute | #medicina

A recent study by the American Society of #Hematology revealed a concerning trend in American hospitals: it takes an average of six months for children to be transferred to the adult section once they come of age. Despite the robust healthcare system, top-notch facilities, and available doctors, this delay poses significant challenges for patients. Factors such as financial constraints and lack of insurance contribute to these delays, leading to potential crises for the affected individuals. If such issues persist in a well-developed #healthcare system, the implications for regions with less developed healthcare infrastructure, such as many parts of #Africa, are even more alarming. Patients in these areas often face greater challenges due to inadequate facilities, limited access to doctors, and overall systemic struggles. This is where #Hemora steps in. Our mission is to bridge the healthcare gap by making #medical care and consultation accessible and affordable. Through our telemedicine platform, we ensure that patients can connect with qualified doctors quickly and efficiently, regardless of their location. Our services are offered at subsidized rates to ensure affordability, further alleviating the financial burden on patients. At Hemora, we are committed to revolutionizing healthcare by providing timely and effective medical attention, ensuring that no patient is left behind due to systemic delays.

Perché il #deprescribing e, più in generale, la revisione delle terapie farmacologiche sono essenziali per migliorare gli esiti clinici nei pazienti anziani affetti da #multimorbilità e in #polifarmacoterapia? Questo è il tema affrontato nell’articolo pubblicato su Epidemiologia&Prevenzione (Rivista dell’Associazione italiana di epidemiologia), scritta da Dott. Massimo Carollo (Università degli Studi di Verona ), Salvatore Crisafulli (Università degli Studi di Verona ), Prof. Graziano Onder (Università Cattolica del Sacro Cuore e Fondazione Policlinico Universitario Agostino Gemelli IRCCS) e Prof. Gianluca Trifirò (Università degli Studi di Verona , Direttore del Corso di Perfezionamento in Medication Review e Deprescribing). La #polifarmacoterapia, diffusa in tutti i contesti assistenziali, aumenta il rischio di interazioni tra farmaci (#DDI) e reazioni avverse (#ADR), spesso dovute a prescrizioni potenzialmente inappropriate, che coinvolgono frequentemente classi di farmaci ampiamente utilizzate, come gli inibitori di pompa protonica, i #FANS e le #benzodiazepine. Leggi l’articolo intero cliccando sul link: https://bit.ly/3NE5gHV #Polifarmacoterapia #MedicationReview #Deprescribing #Salute #CuraDegliAnziani #Farmacologia #FormazioneSanitaria #Geriatria #Farmaci #DDI #FANS #ADR

🌟 Exciting update in the healthcare sector! NICE now recommends abaloparatide for treating osteoporosis in postmenopausal women, trans men, and non-binary individuals at high fracture risk. This new guidance aims to enhance bone health and reduce fracture risks, providing a much-needed alternative for those with limited treatment options. Learn more about the clinical and economic benefits of this recommendation. #SyenzaNews #Healthcare #Osteoporosis #ElderlyCare #NICEGuidance https://lnkd.in/e7K6UYie

La Medicina Narrativa digitale è un modo per tenere contatto con le persone anche a domicilio valutando non tanto a pressione arteriosa o la frequenza cardiaca ma la condizione che la persona sta vivendo attraverso ciò che ci racconta. Una prospettiva molto interessante che prospetta l’approccio alle condizioni di cronicità Visto dal punto di vista della persona malata

Diabetes mellitus poses a serious challenge to healthcare worldwide, affecting millions and stressing healthcare systems. Recent discussions highlight the urgent need for early diagnosis and effective management strategies. This is a pivotal moment for the Information Technology industry, as we explore how technology can enhance diabetes care. The integration of IT in healthcare can drive significant improvements. Innovations such as telemedicine, mobile health apps, and AI-driven analytics enable early detection and ongoing monitoring of diabetes. These tools not only empower patients but also provide healthcare professionals with critical data. As a result, we can achieve better health outcomes while reducing costs for healthcare systems. This shift presents numerous opportunities for tech companies to develop solutions tailored to diabetes management. However, it also comes with challenges such as data privacy concerns and the need for interoperability among various health systems. Addressing these challenges will be crucial as we move forward. I believe this movement toward tech-driven healthcare will reshape the market landscape, fostering collaboration between tech and healthcare professionals. 🌐🤝 I encourage everyone to share their thoughts on how we can leverage technology for better diabetes management and to discuss potential solutions our industry can explore. 💬✨ https://buff.ly/40IhZkn #DiabetesAwareness #ChronicIllness #HealthChallenges #GlobalHealth #EarlyDiagnosis #MetabolicDisorder #HealthcareImpact #DiabetesCare

NUOVO WEBINAR PER I MEDICI "Trasformare la pratica clinica con NutriGen" -A cura del Dr. Baris Tutkun 👨⚕ 📅 Martedì, 21 maggio 2024 ⏰ 6:00 - 7:00 PM CEST (Spagna) Entra nel futuro della medicina personalizzata con il Dr. Baris Tutkun, specialista in chirurgia cardiovascolare ed estetica. Insieme a Laura Vila Vecilla, Ph.D. e Gustavo Torres de Souza, Ph.D., esplorerà casi clinici che mostrano il potere dei piani nutrizionali personalizzati con NutriGen. 🧬 Scopri come le idee del Dr. Tutkun possono rivoluzionare l'approccio alla cura del paziente nella tua pratica clinica: assicurati subito il tuo posto! 👍 ❌ Disponibilità limitata! ❌ Il webinar è in lingua inglese Per iscriversi compila il form al link (disponibile anche nel primo commento)👇 https://lnkd.in/dcWDph7f #FagronPharma #PersonalizingMedicine #galenica #compounding #medicinapersonalizzata #galenicabio #preparazionegalenica #wearefagron #farmacistipreparatori #farmacistiitaliani #sosfarmacia #fagronitalia #FagronFamily #formulazioninaturali #federfarma #farmaciespecializzate #farmacieitaliane #farmaciecomunali #farmacieonline #fitoterapia #nutrigen medicinaestetica #pianonutrizionale #pianonutrizionalepersonalizzato

The future of #dialysis care in the United States faces significant hurdles that threaten to impede progress and the enhancement of patient care. Current systemic issues create an environment where innovation struggles to thrive, and patient outcomes may suffer. This analysis explores the realistic future trends in dialysis care, illustrating how these ongoing challenges will continue to impact the quality and accessibility of treatment for patients Future Trends and Their Detrimental Impact on Dialysis Care 🌍 The dialysis care market is expected to continue consolidating, with fewer large organizations dominating the industry. This consolidation can stifle competition, leading to fewer choices for patients and potentially lower quality care due to the lack of alternative providers. 🚧 Nephrologists often face restrictive employment practices that limit their mobility and ability to innovate. These practices hinder the spread of new ideas and techniques, keeping the industry stagnant and reducing the overall quality of care available to patients. 📉 Financial Pressures: Dialysis providers face significant financial pressures that force them to prioritize cost-saving measures over patient care improvements. This financial strain can result in underfunding of critical services and reduced investment in new technologies, ultimately compromising patient outcomes. ⚖️ Regulatory Compliance Burdens: Smaller and newer dialysis providers struggle to navigate the complex regulatory landscape. These compliance burdens can inhibit their ability to operate effectively, limiting innovation and reducing the diversity of care options available to patients. 🔬 Although advances in technology such as AI and portable dialysis machines hold promise, their adoption is slow due to high costs and logistical challenges. This slow adoption rate means that many patients do not benefit from the latest innovations in treatment. 📊 Large providers with advanced data analytics capabilities will continue to have a competitive advantage, leading to inequities in care quality. Patients at smaller facilities may not receive the same level of personalized care or predictive insights that can improve their health outcomes. 💡 Despite the potential benefits of home dialysis, its expansion is hindered by the costs and complexities involved in setting up home-based treatments. This limitation means that many patients will continue to rely on in-center treatments, which may not be as convenient or effective. 🌟 True patient-centered care requires significant investment and a shift in focus that is difficult to achieve under current financial and operational constraints. As a result, initiatives that aim to engage patients actively in their care are often marginalized, leading to less personalized and effective treatment. #DialysisCareChallenges #HealthcareInnovation #PatientOutcomes #Nephrology #HealthcareBarriers #RegulatoryBurden #MedicalTechnology